pI: 6.3101 |
Length (AA): 1434 |
MW (Da): 168170 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 21 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
4 | 329 | 1jl0 (A) | 6 | 308 | 20.00 | 0 | 1 | 0.06 | 0.27 |
5 | 181 | 1jl0 (A) | 7 | 143 | 37.00 | 0.000009 | 0.91 | 0.22 | -0.01 |
820 | 1260 | 1twi (A) | 15 | 442 | 17.00 | 0 | 1 | 0.38 | 0.1 |
855 | 1050 | 1w8g (A) | 7 | 205 | 13.00 | 0 | 0.75 | 0.14 | -0.69 |
4 | 497 | 1jl0 (A) | 6 | 306 | 26.00 | 0 | 0.99 | -0.255109 | 2.03 |
5 | 181 | 1jl0 (A) | 7 | 143 | 38.00 | 0.0000047 | 0.92 | 0.172231 | 0.72 |
118 | 740 | 3s5k (A) | 60 | 687 | 18.00 | 0.000000057 | 0.99 | 0.459249 | 1.15 |
415 | 473 | 3ep6 (A) | 223 | 281 | 41.00 | 0.1 | 0.98 | 0.424944 | 0.43 |
809 | 1432 | 2oo0 (A) | 0 | 422 | 36.00 | 0 | 1 | 0.170546 | 1.89 |
821 | 1259 | 3n2b (A) | 0 | 410 | 17.00 | 0.00000034 | 1 | 0.312537 | 0.48 |
855 | 1418 | 1f3t (A) | 44 | 408 | 43.00 | 0 | 1 | 0.0871054 | 1.65 |
1183 | 1284 | 3ult (A) | 9 | 113 | 28.00 | 0.58 | 0.38 | 0.33893 | -1.11 |
415 | 473 | 3ep6 (A) | 223 | 281 | 42.00 | 0.055 | 0.99 | 0.444979 | 0.34 |
590 | 730 | 3na7 (A) | 27 | 166 | 14.00 | 0.33 | 0.01 | 0.267566 | -0.46 |
796 | 1417 | 2oo0 (A) | 0 | 422 | 35.00 | 0 | 1 | 0.203537 | 1.56 |
806 | 1258 | 3vab (A) | 0 | 421 | 15.00 | 0 | 1 | 0.340439 | 0.7 |
823 | 1405 | 1f3t (A) | 19 | 410 | 40.00 | 0 | 1 | 0.0980527 | 1.84 |
827 | 1170 | 4aib (B) | 17 | 330 | 31.00 | 0 | 1 | 0.286724 | 0.88 |
829 | 1258 | 1twi (A) | 37 | 446 | 16.00 | 0 | 1 | 0.34923 | 0.45 |
831 | 1216 | 2nva (A) | 12 | 355 | 30.00 | 0.00000000051 | 1 | 0.493223 | 0.3 |
838 | 1259 | 3btn (A) | 40 | 435 | 25.00 | 0.000000000055 | 1 | 0.469593 | -0.01 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, gametocyte, merozoite, sporozoite, early ring, early schizont, early trophozoite, late ring, late schizont, late trophozoite, Oocyst, Ring, Sporozoite, Female Gametocyte. | Otto TD PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Male Gametocyte. | Lasonder E |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Ortholog group members (OG5_126750)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G14390 | diaminopimelate decarboxylase 1 |
Arabidopsis thaliana | AT5G11880 | diaminopimelate decarboxylase 2 |
Brugia malayi | Bm1_56455 | Pyridoxal-dependent decarboxylase, pyridoxal binding domain containing protein |
Candida albicans | CaO19.6032 | Ornithine decarboxylase similar to S. cerevisiae SPE1 (YKL184W) involved in pantothenate and polyamine biosynthesis |
Candida albicans | CaO19.13453 | Ornithine decarboxylase similar to S. cerevisiae SPE1 (YKL184W) involved in pantothenate and polyamine biosynthesis |
Caenorhabditis elegans | CELE_K11C4.4 | Protein ODC-1 |
Dictyostelium discoideum | DDB_G0281109 | Orn/DAP/Arg decarboxylase 2 domain-containing protein |
Dictyostelium discoideum | DDB_G0269856 | Orn/DAP/Arg decarboxylase 2 domain-containing protein |
Drosophila melanogaster | Dmel_CG8719 | Ornithine decarboxylase 2 |
Drosophila melanogaster | Dmel_CG8721 | Ornithine decarboxylase 1 |
Escherichia coli | b2838 | diaminopimelate decarboxylase, PLP-binding |
Entamoeba histolytica | EHI_100430 | ornithine decarboxylase, putative |
Giardia lamblia | GL50803_94582 | Ornithine decarboxylase |
Homo sapiens | ENSG00000115758 | ornithine decarboxylase 1 |
Leishmania braziliensis | LbrM.12.0300 | ornithine decarboxylase, putative |
Leishmania donovani | LdBPK_120105.1 | ornithine decarboxylase, putative |
Leishmania infantum | LinJ.12.0100 | ornithine decarboxylase, putative |
Leishmania major | LmjF.12.0280 | ornithine decarboxylase, putative |
Leishmania mexicana | LmxM.12.0280 | ornithine decarboxylase, putative |
Loa Loa (eye worm) | LOAG_07980 | pyridoxal-dependent decarboxylase |
Mycobacterium leprae | ML1128 | PROBABLE DIAMINOPIMELATE DECARBOXYLASE LYSA (DAP DECARBOXYLASE) |
Mus musculus | ENSMUSG00000023120 | predicted gene 853 |
Mus musculus | ENSMUSG00000011179 | ornithine decarboxylase, structural 1 |
Mycobacterium tuberculosis | Rv1293 | Diaminopimelate decarboxylase LysA (DAP decarboxylase) |
Mycobacterium ulcerans | MUL_3971 | diaminopimelate decarboxylase LysA |
Neospora caninum | NCLIV_067260 | Diaminopimelate decarboxylase protein, related |
Oryza sativa | 4329234 | Os02g0440000 |
Oryza sativa | 4347746 | Os09g0543400 |
Oryza sativa | 4335010 | Os04g0136500 |
Onchocerca volvulus | OVOC1740 |
|
Plasmodium berghei | PBANKA_0516900 | S-adenosylmethionine decarboxylase/ornithine decarboxylase, putative |
Plasmodium falciparum | PF3D7_1033100 | S-adenosylmethionine decarboxylase/ornithine decarboxylase |
Plasmodium knowlesi | PKNH_0617900 | S-adenosylmethionine decarboxylase/ornithine decarboxylase, putative |
Plasmodium vivax | PVX_111070 | S-adenosylmethionine decarboxylase-ornithine decarboxylase, putative |
Plasmodium yoelii | PY04754 | S-adenosylmethionine decarboxylase-ornithine decarboxylase-related |
Saccharomyces cerevisiae | YKL184W | ornithine decarboxylase SPE1 |
Schmidtea mediterranea | mk4.013057.00 | |
Schmidtea mediterranea | mk4.012821.00 | |
Schmidtea mediterranea | mk4.008099.00 | |
Schmidtea mediterranea | mk4.023368.00 | |
Schmidtea mediterranea | mk4.025019.00 | |
Schmidtea mediterranea | mk4.007677.03 | |
Schmidtea mediterranea | mk4.001750.03 | Ornithine decarboxylase-1 |
Schmidtea mediterranea | mk4.000699.03 | |
Schmidtea mediterranea | mk4.014212.00 | |
Schmidtea mediterranea | mk4.005186.01 | |
Schmidtea mediterranea | mk4.021206.00 | |
Schmidtea mediterranea | mk4.016468.00 | |
Schmidtea mediterranea | mk4.022984.00 | |
Schmidtea mediterranea | mk4.008099.01 | |
Schmidtea mediterranea | mk4.008445.00 | |
Schmidtea mediterranea | mk4.000260.08 | |
Schmidtea mediterranea | mk4.009657.00 | |
Schmidtea mediterranea | mk4.003300.00 | |
Trypanosoma brucei gambiense | Tbg972.11.15320 | ornithine decarboxylase, putative |
Trypanosoma brucei | Tb927.11.13730 | ornithine decarboxylase |
Trypanosoma congolense | TcIL3000_0_32090 | ornithine decarboxylase |
Trypanosoma congolense | TcIL3000.11.14030 | ornithine decarboxylase, putative |
Toxoplasma gondii | TGME49_278740 | diaminopimelate decarboxylase |
Trichomonas vaginalis | TVAG_001640 | pyridoxal-dependent decarboxylase, putative |
Trichomonas vaginalis | TVAG_258030 | ornithine decarboxylase, putative |
Trichomonas vaginalis | TVAG_205840 | ornithine decarboxylase, putative |
Trichomonas vaginalis | TVAG_351660 | diaminopimelate decarboxylase, putative |
Trichomonas vaginalis | TVAG_257110 | diaminopimelate decarboxylase, putative |
Trichomonas vaginalis | TVAG_372420 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.5300 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.5300 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.5300 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.5300 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b2838 | Escherichia coli | non-essential | goodall |
PBANKA_0516900 | Plasmodium berghei | Essential | plasmo |
TGME49_278740 | Toxoplasma gondii | Probably non-essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
growth (GO:0040007) | lethal (sensu genetics) (PATO:0000718) | multi-cellular organism (CARO:0000012) | bloodstream stage (PLO:0040) | host (GO:0018995) | Plasmodium berghei | 59964 |
Annotator: | saralph@unimelb.edu.au. | Comment: | 012/Mar/09. | References: | 2463635 | |
growth (GO:0040007) | lethal (sensu genetics) (PATO:0000718) | multi-cellular organism (CARO:0000012) | bloodstream stage (PLO:0040) | in vivo inhibition (TDR:00016) | Plasmodium falciparum | 59964 |
Annotator: | saralph@unimelb.edu.au. | Comment: | 012/Mar/09. | References: | 2463635 | |
catalytic activity (GO:0003824) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Plasmodium falciparum | 59964 | |
Annotator: | saralph@unimelb.edu.au. | Comment: | 012/Mar/09. | References: | 12557188 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.8
Compound | Source | Reference |
---|---|---|
Curated by TDRTargets | References |
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Rattus norvegicus | Ornithine decarboxylase | Compounds | References |
Homo sapiens | ornithine decarboxylase 1 | Compounds | References |
Target | Type | Source | Notes |
---|---|---|---|
PF3D7_1033100 | purified protein | BRENDA | A protein with this EC number or name or sequence has been purified from Plasmodium falciparum ( 3 ) |
30 literature references were collected for this gene.